TY - JOUR
T1 - In vitro proliferative advantage of bone marrow cells with tetrasomy 8 in Ewing sarcoma
AU - Trakhtenbrot, Luba
AU - Neumann, Yoram
AU - Mandel, Matilda
AU - Toren, Amos
AU - Gipsh, Nelly
AU - Rosner, Esther
AU - Rechavi, Gideon
AU - Brok-Simoni, Frida
N1 - Funding Information:
The authors thank Sara Barman for excellent technical assistance. This work was supported in part by the Israel Cancer Research Fund.
PY - 1996/9
Y1 - 1996/9
N2 - We describe a case of a 14.5-year-old boy with a clinically aggressive pelvic Ewing sarcoma. The tumor cells showed the presence of a typical t(11;22)(q24;q12) aberration and gains of chromosomes 8, 10, 14, and 21. To determine the size of the trisomy and tetrasomy 8 clones an interphase analysis by fluorescence in situ hybridization with a centromere-specific chromosome 8 probe was performed. Significant quantitative differences between metaphase and interphase data were obtained. It was shown that culturing of bone marrow cells leads to enrichment of tetrasomy 8 population that may be explained by the proliferative advantage of the tetrasomy 8 cells.
AB - We describe a case of a 14.5-year-old boy with a clinically aggressive pelvic Ewing sarcoma. The tumor cells showed the presence of a typical t(11;22)(q24;q12) aberration and gains of chromosomes 8, 10, 14, and 21. To determine the size of the trisomy and tetrasomy 8 clones an interphase analysis by fluorescence in situ hybridization with a centromere-specific chromosome 8 probe was performed. Significant quantitative differences between metaphase and interphase data were obtained. It was shown that culturing of bone marrow cells leads to enrichment of tetrasomy 8 population that may be explained by the proliferative advantage of the tetrasomy 8 cells.
UR - http://www.scopus.com/inward/record.url?scp=0030249074&partnerID=8YFLogxK
U2 - 10.1016/S0165-4608(96)00090-8
DO - 10.1016/S0165-4608(96)00090-8
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0030249074
SN - 0165-4608
VL - 90
SP - 176
EP - 178
JO - Cancer Genetics and Cytogenetics
JF - Cancer Genetics and Cytogenetics
IS - 2
ER -